Top 10 Companies in the Global 2-Methyl-5-Bromopyridine Market (2026)

Global 2-Methyl-5-Bromopyridine market size was valued at USD 34 million in 2024 and is projected to reach USD 43 million by 2030, at a CAGR of 4.0% during the forecast period 2024‑2030.

United States 2-Methyl-5-Bromopyridine market size was valued at USD 11 million in 2024 and is projected to reach USD 13 million by 2030, at a CAGR of 2.8% during the forecast period 2024‑2030.

Organic compound used as an intermediate in pharmaceutical and agrochemical synthesis. Steady growth driven by demand in drug discovery and development. Increasing research in pyridine‑based compounds. Limited market size due to specialized applications.

Download Detailed Research Report
Global 2-Methyl-5-Bromopyridine Market – View in Detailed Research Report

Market Insight

The 2‑Methyl‑5‑Bromopyridine segment is a niche but strategically important chemical, positioned as a key intermediate in the synthesis of complex heterocycles used in drug development and agrochemical formulations. The market’s modest size reflects its highly specialized role, yet the steady uptick in research and development activity within the pharmaceutical sector keeps demand stable. In the United States, the compound remains a critical component of early‑stage synthesis pipelines, contributing to the country’s leadership in medicinal chemistry.

Product Definition

2‑Methyl‑5‑Bromopyridine (C6H6BrN) is a halogenated heteroaromatic compound that serves as a versatile building block for the construction of advanced pharmacophores. Its bromine substituent provides a reactive handle for cross‑coupling reactions, enabling rapid diversification of molecular libraries.

Top 10 Companies

---

10. Angene International Limited

Headquarters: Hyderabad, India
Key Offering: High‑purity 2‑Methyl‑5‑Bromopyridine for pharmaceutical intermediates

Angene has carved out a reputation for delivering consistent quality across its specialty chemical portfolio. Its 99% purity grade is preferred by contract manufacturers engaged in early‑stage drug discovery.

Sustainability & Growth Initiatives:

• Investing in green chemistry protocols to reduce solvent usage
• Expanding production capacity in India to meet rising domestic demand
• Collaborating with universities on pyridine‑based drug discovery projects

---

9. Boc Sciences

Headquarters: Shenzhen, China
Key Offering: 98% purity 2‑Methyl‑5‑Bromopyridine for agrochemical synthesis

Boc Sciences focuses on delivering cost‑effective intermediates to the agrochemical industry, positioning itself as a reliable supplier for large‑scale production of herbicides and insecticides.

Sustainability & Growth Initiatives:

• Implementing waste‑heat recovery systems in its synthesis units
• Partnering with Chinese agricultural research institutes to develop next‑generation pesticides
• Scaling up production to support the growing demand for specialty agrochemicals

---

8. Karl H. Boddin Chemiehandel GmbH

Headquarters: Düsseldorf, Germany
Key Offering: 99% purity 2‑Methyl‑5‑Bromopyridine for medicinal chemistry

With a strong foothold in the European market, Karl H. Boddin Chemiehandel supplies high‑quality intermediates to contract research organizations and pharmaceutical manufacturers.

Sustainability & Growth Initiatives:

• Adopting ISO 14001 environmental management systems across facilities
• Investing in catalytic cross‑coupling technologies to improve yield
• Expanding distribution networks across Central and Eastern Europe

---

7. General Intermediates

Headquarters: Houston, Texas, USA
Key Offering: 98% purity 2‑Methyl‑5‑Bromopyridine for organic synthesis

General Intermediates is a key supplier to the North American contract manufacturing sector, offering a broad range of specialty intermediates that support complex synthetic routes.

Sustainability & Growth Initiatives:

• Optimizing solvent recycling processes to cut down on waste
• Collaborating with US universities on green cross‑coupling research
• Enhancing supply chain resilience through regional distribution centers

---

6. Struchem

Headquarters: Tokyo, Japan
Key Offering: 99% purity 2‑Methyl‑5‑Bromopyridine for pharmaceutical intermediates

Struchem’s focus on high‑purity intermediates positions it as a preferred partner for Japanese pharmaceutical companies engaged in late‑stage drug synthesis.

Sustainability & Growth Initiatives:

• Deploying advanced membrane filtration for solvent recovery
• Investing in research on sustainable bromination methods
• Expanding product line to include other halogenated pyridines

---

5. Capot Chemical

Headquarters: Seoul, South Korea
Key Offering: 98% purity 2‑Methyl‑5‑Bromopyridine for agrochemical intermediates

Capot Chemical serves the rapidly growing Korean agrochemical market, supplying intermediates that enable the development of advanced crop protection agents.

Sustainability & Growth Initiatives:

• Implementing closed‑loop water systems in synthesis plants
• Partnering with Korean research institutes on next‑generation pesticide platforms
• Scaling production to meet the projected growth in the region

---

4. Jinan Haohua Industry

Headquarters: Jinan, China
Key Offering: 99% purity 2‑Methyl‑5‑Bromopyridine for pharmaceutical intermediates

Jinan Haohua has built a strong presence in the Chinese pharmaceutical market, supplying intermediates that support the development of novel therapeutics.

Sustainability & Growth Initiatives:

• Adopting energy‑efficient catalytic processes
• Investing in R&D for safer bromination techniques
• Expanding distribution to regional hubs across Asia‑Pacific

---

3. Shanghai Linchem

Headquarters: Shanghai, China
Key Offering: 98% purity 2‑Methyl‑5‑Bromopyridine for organic synthesis

Shanghai Linchem supplies a wide array of specialty intermediates to the global market, with a focus on high‑quality, cost‑effective products.

Sustainability & Growth Initiatives:

• Implementing solvent‑free reaction protocols where feasible
• Collaborating with Chinese universities on advanced heterocycle synthesis
• Expanding production capacity to support growing demand in Asia

---

2. ABE Medchem Corporation

Headquarters: New Delhi, India
Key Offering: 99% purity 2‑Methyl‑5‑Bromopyridine for pharmaceutical intermediates

ABE Medchem serves both domestic and international contract manufacturers, providing intermediates that enable the rapid synthesis of complex drug candidates.

Sustainability & Growth Initiatives:

• Investing in green chemistry training for staff
• Partnering with Indian pharmaceutical research centers on novel synthesis routes
• Scaling up production to meet rising demand in the region

---

1. Hangzhou Dayangchem

Headquarters: Hangzhou, China
Key Offering: 98% purity 2‑Methyl‑5‑Bromopyridine for agrochemical intermediates

Hangzhou Dayangchem is a key player in the Chinese agrochemical sector, supplying intermediates that support the development of next‑generation crop protection solutions.

Sustainability & Growth Initiatives:

• Implementing waste‑reduction programs across manufacturing sites
• Investing in research on sustainable bromination processes
• Expanding regional distribution networks to cover emerging markets

---

Download FREE Sample Report
Global 2-Methyl-5-Bromopyridine Market – View in Detailed Research Report

Get Full Report
Global 2-Methyl-5-Bromopyridine Market – View in Detailed Research Report

Outlook

The 2‑Methyl‑5‑Bromopyridine market is poised to maintain a stable trajectory, driven by ongoing investment in drug discovery pipelines and the expansion of agrochemical R&D. The compound’s unique reactivity continues to make it a valuable tool for chemists seeking to build complex heterocyclic architectures.

Future Trends

• Growth of cross‑coupling chemistry in pharmaceutical synthesis, boosting demand for halogenated pyridines
• Increasing focus on green bromination methods to reduce environmental impact
• Expansion of production capacity in Asia‑Pacific to meet regional demand spikes
• Strategic collaborations between specialty chemical suppliers and contract research organizations to accelerate development timelines